Board director resigns over Chemours’ abortion benefits policy

A board director of Chemours Co. resigned after the chemical products and solutions company’s decision to provide new employee benefits that include coverage for abortions, MarketWatch reports. Bradley Bell, in the letter, said he disagreed with the company’s decision to provide medical benefits for employees and their dependents related to abortions as well as transgender procedures, plus benefits for those who need to travel more than 100 miles to receive those services.